| Financial Year |
March 31 2023 |
| Monetary Funds |
115,568,817.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,534,835.40 |
| Accounts Receivable |
355,908,895.92 |
| Advances to Suppliers |
23,231,407.86 |
| Other Receivables |
3,209,212.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
206,797,304.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,503,949.39 |
| Total Current Assets |
740,302,339.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
806,424.34 |
| Investment Properties |
44,399,406.67 |
| Fixed Assetes |
266,887,057.10 |
| Under-construction Projects |
2,719,041.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,681,098.41 |
| R&D expenses |
-- |
| Goodwill |
931,309.53 |
| Long-Term Deferred and Prepaid Expenses |
183,041.56 |
| Deferred Income Tax Assets |
57,969,862.55 |
| Other Non-Current Assets |
126,256.00 |
| Sub-Total of Non-Current Assets |
421,707,958.87 |
| Total Assets |
1,162,010,298.01 |
| Short-Term Loans |
119,280,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,476,408.45 |
| Accounts Payable |
83,943,744.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,813,721.81 |
| Taxes Payable |
6,810,148.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
313,241.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,764,367.22 |
| Sub-Total of Current Liabilities |
297,483,149.31 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,821.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
700,321.56 |
| Total Liabilities |
298,183,470.87 |
| Paid-In Capital(Or Share Stock) |
294,234,480.00 |
| Capital Surplus |
317,554,380.01 |
| Surplus Reserve |
71,711,010.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
175,769,373.31 |
| Minority Stockholder's Interest |
4,557,582.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
859,269,244.31 |
| Owner's Equity（Stockholder's Equity） |
863,826,827.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,162,010,298.01 |
